Real-time enrollment status for this large b-cell lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:12 AM UTC
| NCT Number | NCT06356129 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Large B-cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 850 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Celgene |
| Last Updated on CT.gov | February 12, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06356129 is currently active_not_recruiting participants. This clinical trial study for large b-cell lymphoma is not currently accepting new participants at 47 locations across the United States. The study is sponsored by Celgene. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06356129 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06356129 was last updated 2 weeks ago (February 12, 2026). HelloStudys verifies this status automatically.